GroupAccess > Drug Coverage Guidelines

You are not signed in.

myBlueCross for Members
Forgot Username?
Forgot Password?

New to GroupAccess?

Search by Drug Name

  

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Product Name Implementation Date Guideline
COMETRIQ® 04/01/13 Prior authorization for medical necessity is required. The limits are 1 kit/28 days.
COMPLERA 07/01/12 The limits are 1 tablet per day.
COMPOUNDS 01/01/00 Prior authorization for medical necessity may be required.
CONCERTA® 11/01/02 The limits are 2 tablets per day.
CONZIP® 01/01/12 The limits are 30 capsules per 30 days.
COPAXONE® 10/01/12 The limits are 1 carton of 30 syringes per 30 days.
CORLANOR® 10/01/15 Prior Authorization for medical necessity may be required. Quantity limits are 2 tablets per day.
COSENTYX® 04/01/15 Cosentyx may be subject to step therapy requirements. Patients must have trial and failure of 2 preferred products. Preferred products are Humira, Enbrel, Stelara, and Simponi. Quantity limits apply based on package size.
COTELLIC 11/25/15 Prior authorization for medical necessity is required. The limits are 63 tablets per 30 days.
COZAAR® 01/01/11 Cozaar may be subject to step therapy requirements. Patients must have trial and failure of a generic ACE inhibitor or generic ARB.
CRESTOR® 01/01/11 Crestor may be subject to step therapy requirements. Patients must have trial and failure of generic statin (lovastatin, pravastatin, simvastatin).
CRIXIVAN 07/01/12 The limits are 9 capsules per day for 200 mg, and 6 capsules per day for 400 mg strengths.
CYMBALTA® 09/01/04 The limits are 2 capsules per day, except Cymbalta 60mg with a limit of 1 capsule per day.
DAKLINZA® 08/14/15 Prior authorization for medical necessity is required. Quantity limits may apply based on strength.
DANAZOL 04/01/12 Prior authorization for medical necessity is required.

« Prev 7 8 9 10 11 Next »